F W Blaisdell. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Drug EvaluationHeparin/administration & dosageHeparin/therapeutic useHumansInjections, SubcutaneousLeg/blood supplyPostoperative Complications/prevention & controlThrombophlebitis/prevention & controlWounds and Injuries/complications
Substances: See more » Heparin
Year: 1979 PMID: 433745 DOI: 10.1016/0002-8703(79)90001-2
Source DB: PubMed Journal: Am Heart J ISSN: 0002-8703 Impact factor: 4.749